High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 9,646 followers.

RT @ChristieLibrary: Christie Researchers High-dose interleukin2 in treatment of metastatic renal cell carcinoma: https://t.co/OoNuQPTqbd O…

RT @ChristieLibrary: Christie Researchers High-dose interleukin2 in treatment of metastatic renal cell carcinoma: https://t.co/OoNuQPTqbd O…

RT @ChristieLibrary: Christie Researchers High-dose interleukin2 in treatment of metastatic renal cell carcinoma: https://t.co/OoNuQPTqbd O…

Christie Researchers High-dose interleukin2 in treatment of metastatic renal cell carcinoma: https://t.co/OoNuQPTqbd Open Access

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.